mutLBSgeneDB |
Gene summary for RNASEL |
Gene summary |
Basic gene Info. | Gene symbol | RNASEL |
Gene name | ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) | |
Synonyms | PRCA1|RNS4 | |
Cytomap | UCSC genome browser: 1q25 | |
Type of gene | protein-coding | |
RefGenes | NM_021133.3, | |
Description | 2',5'-oligoisoadenylate synthetase-dependent2-5A-dependent RNase2-5A-dependent ribonucleaseRNase Linterferon-induced 2-5A-dependent RNaseribonuclease 4 | |
Modification date | 20141207 | |
dbXrefs | MIM : 180435 | |
HGNC : HGNC | ||
Ensembl : ENSG00000135828 | ||
HPRD : 01590 | ||
Vega : OTTHUMG00000035213 | ||
Protein | UniProt: Q05823 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RNASEL | |
BioGPS: 6041 | ||
Pathway | NCI Pathway Interaction Database: RNASEL | |
KEGG: RNASEL | ||
REACTOME: RNASEL | ||
Pathway Commons: RNASEL | ||
Context | iHOP: RNASEL | |
ligand binding site mutation search in PubMed: RNASEL | ||
UCL Cancer Institute: RNASEL | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0045071 | negative regulation of viral genome replication | 19923450 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 19245366 | GO:0051607 | defense response to virus | 19923450 |
Top |
Ligand binding site mutations for RNASEL |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | I101 | A102V | COAD | 1 | G58,W60 | G59D | COAD | 1 | F647 | K646T | COAD | 1 | G167 | G168W | LUAD | 1 | I101 | A102V | LUAD | 1 | Q34 | V33A | SKCM | 1 | E55 | F53L | UCEC | 1 | M644 | K642E | UCEC | 1 | D505 | S507N | UCEC | 1 | D485 | D485Y | UCEC | 1 | I101 | A99T | UCEC | 1 | R155 | R155Q | UCEC | 1 | R310 | R310W | UCEC | 1 | R400 | R400H | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for RNASEL |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | I101 | A102V | 0.35825025 | R155 | R155Q | -1.4767862 | Q34 | V33A | -1.3315772 | D505 | S507N | -1.2248697 | W60 | G59D | -1.0358632 | G58 | G59D | -1.0358632 | R400 | R400H | -1.0141247 | M644 | K642E | -0.76715948 | D485 | D485Y | -0.76084175 | I101 | A99T | -0.6716086 | F647 | K646T | -0.66119415 | R310 | R310W | -0.61865047 | G167 | G168W | -0.31624728 | E55 | F53L | -0.25806037 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for RNASEL from PDB |
Top |
Differential gene expression and gene-gene network for RNASEL |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for RNASEL |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0033578 | Prostatic Neoplasms | 21 | AlteredExpression, Biomarker, GeneticVariation |
umls:C2931456 | Prostate cancer, familial | 15 | Biomarker, GeneticVariation |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for RNASEL |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of RNASEL go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | MG | MAGNESIUM(2+) | 4oau | C | D485 D505 | MG | MAGNESIUM(2+) | 4oav | B | D485 D505 | ADP | ADP | 4oau | C | D505 | MG | MAGNESIUM(2+) | 4oav | D | D505 | 25A | 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE | 4g8l | B | E55 G58 W60 I101 R155 | 25A | 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE | 4g8l | C | E55 G58 W60 I101 R155 | NUC | Nucleic Acids | 4oau | C | E55 G58 W60 I101 R155 | NUC | Nucleic Acids | 4oav | D | E55 G58 W60 I101 R155 G167 | 25A | 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE | 1wdy | A | E55 G58 W60 R155 | 25A | 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE | 4g8l | A | E55 G58 W60 R155 | 25A | 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE | 4g8l | D | E55 G58 W60 R155 | PUP | (2R,3S,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)- YL)-4-HYDROXY-2-({[(S)-HYDROXY{[(2R,3S,4S)-4-HYDROXY- 2-(HYDROXYMETHYL)TETRAHYDROFURAN-3- YL]OXY}PHOSPHORYL]OXY}METHYL)TETRAHYDROFURAN-3-YL DIHYDROGEN PHOSPHATE | 4oav | D | M644 F647 | NUC | Nucleic Acids | 4oav | B | Q34 E55 G58 W60 R155 G167 | NUC | Nucleic Acids | 4oav | B | R310 | NUC | Nucleic Acids | 4oav | D | R310 | ACP | ADENOSINE 5'-[BETA,GAMMA-METHYLENE]TRIPHOSPHATE | 4oav | B | R400 D505 | ACP | ADENOSINE 5'-[BETA,GAMMA-METHYLENE]TRIPHOSPHATE | 4oav | D | R400 D505 |
Top |
Conservation information for LBS of RNASEL |
Multiple alignments for Q05823 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |